Recombinant Avian Ovalbumin for Egg-White Gelation Replacement

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for sustainable, non-animal-based sources of protein to meet the growing global food demand, as the majority of protein intake currently comes from animal-based sources.

Innovation Solution

Development of recombinant avian ovalbumins, specifically from pigeon, hamerkop, and collard flycatcher, which are expressed in yeast cells and can be used as egg-white substitutes in food products, providing equivalent or superior gelation properties.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If animal-based protein sources are used, then protein quality and availability are ensured, but sustainability and ethical concerns deteriorate

Engineering Contradiction:
Improveprotein qualityVSAvoidsustainability
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent creates recombinant copies of avian ovalbumin proteins using synthetic biology. The amino acid sequences of egg white proteins are replicated in microbial hosts (yeast or bacteria), producing identical or highly similar protein structures without requiring actual eggs or animals. This copying approach maintains the functional properties of animal-based proteins while eliminating the need for animal farming and egg production.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent introduces microbial cells (yeast or bacteria) as intermediary organisms to produce the desired proteins. These microbial factories serve as mediators between genetic blueprints and functional protein products, enabling the synthesis of high-quality proteins without direct animal involvement. The intermediaries convert simple substrates into complex protein structures through recombinant expression systems.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If plant-based protein alternatives are developed, then sustainability improves, but functional properties (gelation, foaming) deteriorate

Engineering Contradiction:
ImprovesustainabilityVSAvoidfunctional properties
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent modifies the molecular parameters of recombinant proteins to optimize their functional properties. By adjusting amino acid sequences, post-translational modifications, and protein folding conditions, the recombinant ovalbumins achieve gelation and foaming capabilities comparable to or exceeding natural egg whites. The microbial expression system allows precise control over protein structure and properties.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates composite protein formulations by combining recombinant ovalbumin with other proteins or functional ingredients. These composite materials synergistically enhance gelation strength, foaming stability, and water-holding capacity, achieving functional performance that surpasses individual plant-based alternatives while maintaining sustainability advantages.

Inventive Principle:
Principle #40Composite materials

3Reliability

If egg white protein is used in food products, then desired functional properties are achieved, but animal-derived ingredients and allergens are introduced

Engineering Contradiction:
Improvefunctional propertiesVSAvoidallergens
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent extracts only the essential functional components of egg white (ovalbumin proteins) while leaving behind all harmful elements (allergens, cholesterol, bacteria, animal byproducts). Through selective recombinant expression of specific protein sequences, the invention isolates the beneficial gelation and foaming properties without co-introducing any animal-derived contaminants or allergenic epitopes.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent employs single-use microbial cells as temporary protein factories. These microbial hosts are grown, harvested for protein expression, and then discarded or repurposed, eliminating the need for persistent animal farming infrastructure. The microbial cells serve as disposable intermediaries that can be rapidly produced and eliminated without long-term environmental or ethical concerns.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Data Source

PatentUS20260060277A1Recombinant proteins, compositions, and methods of using same
Publication Date: 2026.03.05 EGGMENTED REALITY LTD
  • US20260060277A1 patent drawing
  • US20260060277A1 patent drawing
  • US20260060277A1 patent drawing

AI summary

The present invention provides an edible composition including at least one: recombinant pigeon ovalbumin, recombinant hamerkop ovalbumin, or recombinant collard flycatcher ovalbumin. Further provided are a food product including the edible composition of the invention, as well as a method for preparing same.